Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Hedge Funds Bet Big On Johnson & Johnson: Top Healthcare Stock to Watch

November 30, 2024
Hedge funds have made a significant investment in Johnson & Johnson (JNJ), making it a top healthcare stock to watch. With its strong track record and promising future, JNJ has attracted the attention of these major players in the financial industry. The company's diverse portfolio, which includes pharmaceuticals, medical devices, and consumer health products, provides a stable foundation for growth and profitability. Investors are encouraged to consider buying JNJ stocks and seeking the professional advice of Stocks Prognosis for forecasts on its movement in the market.

Find out how the JOHNSON & JOHNSON rate is expected to change

Get Forecast for JNJ

Investor opinions & comments:

I'm curious to see how much of an impact this investment from hedge funds will have on JNJ's stock price
— from PennyPaul at 12-03-2024 07:53
I'm concerned about issues such as potential lawsuits that could impact JNJ's profitability
— from AnnaDuncan at 12-03-2024 04:39
It's great to see JNJ getting recognition from major players in the financial industry. This could be a positive sign for the company's future
— from AubreyCook at 12-02-2024 20:17
I'm not so sure about investing in JNJ. The healthcare industry can be unpredictable, and there's always the risk of regulatory issues
— from RiskyRandy at 12-02-2024 14:16
I trust the track record of hedge funds, so I might consider adding JNJ to my investment portfolio
— from GrowthGina at 12-02-2024 13:58
I wonder what other healthcare stocks these hedge funds are investing in
— from WealthyWhitney at 11-30-2024 21:46
I've been following JNJ for a while now, and I'm confident that it has the potential to outperform other healthcare stocks
— from SavingsSarah at 11-30-2024 19:13
JNJ's diverse portfolio makes it a strong bet for long-term growth and stability
— from WealthyMary at 11-30-2024 18:29
I've always considered JNJ to be a solid investment, so this news doesn't surprise me
— from GrowthGreg at 11-30-2024 04:53
I'm hesitant to jump on the bandwagon just because hedge funds are investing in JNJ. I need to do my own research before making any decisions
— from SaraBrown at 11-30-2024 03:25
If you want to leave a comment, then you need Login or Register





Other news for JNJ

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....



Related news

REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....

REGNFebruary 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....

ABBVNovember 27, 2024AbbVie Executives to Present at Citi's 2024 Global Healthcare Conference  ~1 min.

AbbVie Inc. (ABBV) has announced that its executives will be presenting at Citi's 2024 Global Healthcare Conference....

ABBVNovember 26, 2024AbbVie Inc. Executes Impressive Performance at Citis 2024 Global Healthcare Conference  ~1 min.

AbbVie Inc., a leading pharmaceutical company, recently showcased its strong growth potential and innovative product portfolio at the Citis 2024 Global Healthcare Conference....

BMYJanuary 4, 2025Bristol-Myers Squibb Company to Expand its Healthcare Offerings at J.P. Morgan Conference  ~1 min.

Bristol-Myers Squibb Company (BMY) is set to present at J.P. Morgan's 43rd Annual Healthcare Conference, showcasing its latest advancements and achievements in the pharmaceutical industry....